Welcome to Probiodrug
Pioneering Therapeutics for Common Degenerative Disorders
Probiodrug AG is a biopharmaceutical company focused on the development of innovative oral drugs for the treatment of major age related diseases.
Latest News
2013-03-06
Probiodrug Sponsoring Symposium to Share Research Findings in the Role of Pyroglutamated Abeta in the Progression of Alzheimer’s Disease … more
2013-01-23
Probiodrug AG Strengthens Management Team and Expands Global Reach with Appointments of Ronald Black and Inge Lues … more
2012-05-02
Probiodrug AG, Collaborators Explain Interplay of Key Suspects in Alzheimer’s Disease … more